Published in AJR Am J Roentgenol on November 01, 1988
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int (1993) 1.96
Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut (1993) 1.83
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Epidemiology, treatment and costs of osteoporosis in Germany--the BoneEVA Study. Osteoporos Int (2006) 1.75
Acute physiological effects of exhaustive whole-body vibration exercise in man. Clin Physiol (2000) 1.72
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int (2010) 1.68
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand (2005) 1.67
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66
Bone-muscle strength indices for the human lower leg. Bone (2000) 1.65
Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group. Osteoporos Int (1999) 1.59
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milano) (2000) 1.59
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions. J Musculoskelet Neuronal Interact (2010) 1.53
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol (1995) 1.51
Oxygen uptake during whole-body vibration exercise: comparison with squatting as a slow voluntary movement. Eur J Appl Physiol (2001) 1.49
Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women. Psychiatry Res (1993) 1.48
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Breast (2009) 1.47
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Deficits in fronto-posterior interactions point to inefficient resource allocation in schizophrenia. Acta Psychiatr Scand (2010) 1.42
Identification of the nervus intermedius using 3T MR imaging. AJNR Am J Neuroradiol (2011) 1.42
Oxygen uptake in whole-body vibration exercise: influence of vibration frequency, amplitude, and external load. Int J Sports Med (2002) 1.41
Intestinal infection by terrestrial Isopoda (Oniscus spp.) and Oligochaeta (Lumbricus spp.) Trans R Soc Trop Med Hyg (1984) 1.41
Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur J Biochem (1992) 1.38
Osteoporosis changes the amount of vertebral trabecular bone at risk of fracture but not the vertebral load distribution. Spine (Phila Pa 1976) (2001) 1.24
Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int (2001) 1.17
Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. Eur J Pharmacol (1986) 1.17
Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry (2004) 1.16
Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). Bone (2007) 1.15
Reference values for trabecular and cortical vertebral bone density in single and dual-energy quantitative computed tomography. Eur J Radiol (1989) 1.14
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int (2011) 1.13
Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int (2000) 1.13
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci (1999) 1.12
Soil diversity and hydration as observed by ChemCam at Gale crater, Mars. Science (2013) 1.10
Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int (2004) 1.10
European semi-anthropomorphic spine phantom for the calibration of bone densitometers: assessment of precision, stability and accuracy. The European Quantitation of Osteoporosis Study Group. Osteoporos Int (1995) 1.08
Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis. Osteoporos Int (1997) 1.06
Long-term visual outcome of pigment epithelial tears in association with anti-VEGF therapy of pigment epithelial detachment in AMD. Eye (Lond) (2011) 1.06
Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res (1997) 1.05
Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol (2009) 1.05
High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut (2002) 1.04
The course of alcoholism. Long-term prognosis in different types. Forensic Sci Int (1988) 1.03
Pregnancy-related admissions to the intensive care unit. Int J Obstet Anesth (2004) 1.03
Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study. Osteoporos Int (2011) 1.03
Recovery of muscle atrophy and bone loss from 90 days bed rest: results from a one-year follow-up. Bone (2008) 1.01
Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann N Y Acad Sci (1985) 1.00
Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry (1995) 1.00
Adjusting for the partial volume effect in cortical bone analyses of pQCT images. J Musculoskelet Neuronal Interact (2004) 0.99
Primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr (1988) 0.98
Resistive vibration exercise reduces lower limb muscle atrophy during 56-day bed-rest. J Musculoskelet Neuronal Interact (2009) 0.97
Resistive vibration exercise attenuates bone and muscle atrophy in 56 days of bed rest: biochemical markers of bone metabolism. Osteoporos Int (2009) 0.96
Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther (2002) 0.95
Automatic multimodal 2D/3D breast image registration using biomechanical FEM models and intensity-based optimization. Med Image Anal (2012) 0.95
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum (1996) 0.95
TBS result is not affected by lumbar spine osteoarthritis. Osteoporos Int (2014) 0.94
Evidence for an additional effect of whole-body vibration above resistive exercise alone in preventing bone loss during prolonged bed rest. Osteoporos Int (2010) 0.94
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Osteoporos Int (2011) 0.94
Measurements of vertebral shape by radiographic morphometry: sex differences and relationships with vertebral level and lumbar lordosis. Skeletal Radiol (1998) 0.93
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93
Decline of specific peak jumping power with age in master runners. J Musculoskelet Neuronal Interact (2008) 0.92
Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol (1992) 0.92
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporos Int (2007) 0.92
Fractal analysis of proximal femur radiographs: correlation with biomechanical properties and bone mineral density. Osteoporos Int (1999) 0.91
Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Rofo (2011) 0.91
Pregnancy in a 31 in. (77.5 cm.) dwarf. Br Med J (1965) 0.91
Peri/intraventricular haemorrhage: a cranial ultrasound study on 5286 neonates. Eur J Obstet Gynecol Reprod Biol (1997) 0.91
Central giant cell granuloma of the mandible. J Oral Maxillofac Surg (1983) 0.90
Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension. Osteoporos Int (2012) 0.90
[Procedures according to data protection laws for coupling primary and secondary data in a cohort study: the lidA study]. Gesundheitswesen (2012) 0.90
Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int (2009) 0.90
Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention. J Musculoskelet Neuronal Interact (2007) 0.90
DCE-MRI of the breast in a stand-alone setting outside a complementary strategy - results of the TK-study. Eur Radiol (2015) 0.90
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis. Osteoporos Int (2007) 0.90
Efficacy and safety of ibandronate given by intravenous injection once every 3 months. Bone (2004) 0.89
[MRI of the knee joint of young soccer players. Are there early changes of the internal structures of the knee due to competitive sports?]. Rofo (1994) 0.89
Emotional and behavioural problems in children and adolescents with primary headache. Cephalalgia (2003) 0.89
Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum (1994) 0.89
Low grip strength is associated with bone mineral density and vertebral fracture in women. Rheumatology (Oxford) (2005) 0.89
European semi-anthropomorphic phantom for the cross-calibration of peripheral bone densitometers: assessment of precision accuracy and stability. Bone Miner (1994) 0.89
Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies. Osteoporos Int (2013) 0.88
The pill and the pituitary. Br Med J (1972) 0.88
Dual X-ray absorptiometry--cross-calibration and normative reference ranges for the spine: results of a European Community Concerted Action. Bone (1995) 0.88
Falls explain between-center differences in the incidence of limb fracture across Europe. Bone (2002) 0.88
Dual X-ray absorptiometry of the proximal femur: normal European values standardized with the European Spine Phantom. J Bone Miner Res (1995) 0.87
Kinetics of rhodopsin bleaching in the isolated human retina. J Physiol (1973) 0.87
On the significance of magnesium in extreme physical stress. Cardiovasc Drugs Ther (1998) 0.86
Vertebral fractures in men and women: how discriminative are bone mass measurements? Br J Radiol (1995) 0.86
Young chronic patients and substance abuse. Hosp Community Psychiatry (1989) 0.86
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int (2002) 0.86
The 2nd Berlin BedRest Study: protocol and implementation. J Musculoskelet Neuronal Interact (2010) 0.86
Whole body vibration in cystic fibrosis--a pilot study. J Musculoskelet Neuronal Interact (2008) 0.86
The three carboxy-terminal amino acids of human interleukin-6 are essential for its biological activity. FEBS Lett (1990) 0.85